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Symposium
The Genetic Nondiscrimination in Health
Insurance and Employment Act: H.R. 602
Congresswoman Louise Slaughter*
Good afternoon! I am delighted to join you for today's sympo-
sium, "Personal Genetic Information: Implications for the Work-
place and Criminal Justice." I would like to extend a special thanks
to New York Law School and its Journal of Human Rights for invit-
ing me to participate.
Let us then dive right into the matter at hand: the ethical, legal,
and social implications of genetic research, and its consequences for
public policy. I will explore three areas: the current situation and
need for legislation; my proposal to ban genetic discrimination; and
the outlook for Congressional action on my bill. I will then invite
each of you to be part of the solution to end genetic discrimination
in health insurance and employment.
THE PROBLEM AND THE NEED FOR LEGISLATION
Most of us would agree at the outset that genetic discrimina-
tion is wrong.1 This being law school, however, we will make no
assumptions and lay out a clear and cogent argument. Let me take
a few moments to explain four key reasons why I believe discrimi-
nation based on predictive genetic information should be illegal.
* Congresswoman Louise McIntosh Slaughter is serving her eighth term in
the U.S. House of Representatives, representing the 2 8th Congressional District of
New York State. Congresswoman Slaughter sits on the House of Rules Committee
and its Subcommittee on Rules and Organization of the House. She is Vice-Chair-
woman of the Research Committee of the Democratic leadership and serves as
whip-at-large.
1 See 42 U.S.C. § 1981 (2001) (federal law protecting certain individual
rights against non-governmental discrimination and discrimination under color of
state law). The Supreme Court has found that § 1981 protects at least discrimina-
tion directed against an individual based on being part of a genetically distinctive
ethnic and physiognomic group of homo-sapiens. See Saint Francis College v. Al-
Khazraji, 481 U.S. 604 (1987). Discrimination based on factors including genetic
predisposition is explicitly proscribed in New York's Human Rights Law. See N.Y.
EXEC. L. § 296 (2001).
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1. Genetic science is not yet fully understood. Immediately following
the discovery of the first breast cancer gene, scientists estimated
that having this gene conferred an 85% risk of developing breast
cancer. 2 Within two years, however, the risk had been downgraded
to only 50 percent.3 Over time, we will further refine our under-
standing of these and other genes, as well as the interplay among
genes and the impact of the environment. Using genetic informa-
tion to discriminate at this point in time is so inaccurate as to be
almost useless 4 - especially in the context of determining who
should get a job, or who should be eligible for affordable insurance.
2. Having a predictive gene does not necessarily mean you will ever
get sick. And even if you do, the disorder might not develop for 10,
20, or 30 years. 5 No one should be passed over for a promotion at
work or lose their insurance coverage simply because they might get
sick someday.
3. We all have genetic flaws. Dr. Francis Collins, Director of the
National Human Genome Research Institute, is frequently quoted
as saying every human being is estimated to have between 5 and 50
significant genetic mutations, making us all ultimately unemploya-
ble and uninsurable. 6 By allowing genetic discrimination to persist,
we effectively penalize the people who happen to have the genes
that were discovered first. 7
2 See Thomas H. Maugh II, Discovery of Breast Cancer Gene Called Major
Advance, L.A. TIMES, September 15, 1994, at 1. See also OncorMed Licenses Ge-
netic Markers for Breast and Ovarian Cancer from the University of California,
BIOTECH PATENT NEWS, No. 9, Vol. 10, Sept. 1, 1996.
3 See Stephanie Slon, The Breast Cancer Gene, (1999) available at http://
www.cnn.com/HEALTH/cancer/9905/26/breast.cancer.gene; see also JOAN SWIR-
SKY AND BARBARA BALABAN, THE BREAST CANCER HANDBOOK - TAKING CON-
TROL AFTER YOU'VE FOUND A LUMP, at 124 (2 nd Ed. 1998).
4 Michael R. Costa, Genetic Testing: International Strategies To Prevent Po-
tential Discrimination In Insurance Risk Classification, 20 SUFFOLK TRANSNAT'L L.
REV. 109, 113 (1996); Natalie E. Zindorf, Discrimination in the 21st Century: Pro-
tecting The Privacy Of Genetic Information In Employment and Insurance, 36
TULSA L.J. 703 (2001).
5 The ASHG Ad Hoc Committee on Breast & Ovarian Cancer Screening,
Statement of the American Society of Human Genetics on Genetic Testing for Breast
& Ovarian Cancer Predisposition, AM. J. GENET. 55 i-iv (1994).
6 See e.g., ABC Good Morning America (ABC television broadcast, Sept.
30, 1998) (statement by Francis Collins directly on point).
7 See e.g., Elaine Draper, The Screening of America: The Social and Legal
Framework of Employers' Use of Genetic Information, 20 BERKELEY J. EMPLOY-
[Vol. XVIII
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4. Both employers and insurers have managed to do just fine for
many years without having access to genetic information. In case
you have not noticed, the insurance industry is highly profitable,
and has been for decades. 8 Today, very little "individual underwrit-
ing" goes on 9 - that is, few people obtain insurance based on their
own specific medical record. Most Americans receive their cover-
age through group plans that base rates on actuarial estimates of
the incidence of health problems.10 Furthermore, very little - if
any - genetic information has any bearing on an individual's abil-
ity to perform a given job.1 Employment decisions should be
based on a person's job performance and merit, not his or her
genes.
In the face of this uncertainty, the logical course is to ban all
genetic discrimination, rather than allowing a "Wild West," any-
thing-goes atmosphere to prevail. The abuse of genetic information
has the potential to destroy individuals' careers and do long-term
damage to their and their families' health.' 2 We must err on the
side of caution and ban all genetic discrimination in health insur-
ance and employment.
THE GENETIC NONDISCRIMINATION IN HEALTH INSURANCE AND
EMPLOYMENT ACT
For all of these reasons, I am proud to be the author of H.R.
602, the Genetic Nondiscrimination in Health Insurance and Em-
ployment Act.13 As its title suggests, the bill would prevent both
MENT & LAB. L. 286, 315 (1999) (encouraging anti-discrimination laws to prevent
penalizing individuals that are genetically predisposed).
8 See e.g., David Wanetick, Chairman, NYSSA 5 h Annual Insurance Confer-
ence, Jan. 29-30, 2001, at http://www.nyssa.org/events/insurance200l.html (last vis-
ited December 6, 2001).
9 See Thomas H. Murray, Genetics and the Moral Mission of Health Insur-
ance, HASTINGS CENTER REPORT. Vol. 22, No. 6, Nov. 1992, at 12; see also Peter
Pockley, et al., Insurers Inconsistent Over HIV, BRIT. MED. J., Vol. 306, No. 6891,
June 1993, at 1495.
10 See Katharine R. Levit et al., Nat'l Health Care Spending Trends, 9
HEALTH AFF. 177, 177 (1990).
11 See Tamar Lewin, Commission Sues Railroad to End Genetic Testing in
Work Injury Cases, N.Y.TIMES, Feb. 10, 2001, at A10.
12 See Researchers Find Signs of Genetic Discrimination by Insurers, FED-
ERAL & STATE INSURANCE WEEK, No. 14, Vol. 10, April 15, 1996.
13 H.R. 602, 107 th Cong. § 714 (d) (2001); S. 318, 107" Cong. § 714 (d) (2001).
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health insurance companies and employers from using genetic in-
formation to discriminate against individuals.
With regard to health insurance discrimination, H.R. 602 would:
* cover all health insurance programs, including
those regulated by the federal government, state-
regulated plans, and the individual market;
* prohibit insurers from restricting enrollment or
changing premiums on the basis of predictive ge-
netic information or genetic services;
" ban health plans and insurers from requesting or
requiring that an individual take a genetic test, or
reveal the results of such a test; and
" prohibit health plans and insurers from pursuing or
being provided information on predictive genetic
information or genetic services.
1 4
With regard to employment discrimination, H.R. 602 would:
* cover employers, employment agencies, labor orga-
nizations, and training programs;
* prevent discrimination in hiring, compensation, and
other personnel processes;
• prohibit employers from requiring or requesting
disclosure of predictive genetic information, and al-
low genetic testing only to monitor the adverse ef-
fects of hazardous workplace exposures; and
" require predictive information possessed by em-
ployers to be confidentially maintained and dis-
closed only to the employee upon request, or to
researchers (under strict guidelines). 15
Both health insurance and employers would be subject to stiff
penalties for violating either the nondiscrimination or privacy pro-
visions of this law.' 6 The Secretary of Health and Human Services
may impose civil money penalties, and individuals may pursue a
private right of action.17 Without such sanctions, including the right
to sue, the law becomes little more than a paper tiger. Strong en-
14 H.R. 602, 107 th Cong. § 714 (d 12001); S. 318, 107th Cong. § 714 (d) (2001)
15 H.R. 602, 107th Cong. § 714 (d 2001); S. 318, 1 07th Cong. § 714 (d) (2001)
16 H.R. 602, 107th Cong. § 714 (d 2001); S. 318, 107th Cong. § 714 (d) (2001).
17 H.R. 602, 107h Cong. § 714 (d 2001); S. 318, 1 07th Cong. § 714 (d (2001).
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forcement provisions are necessary to show that Congress is serious
about this matter.
I am pleased to report that H.R. 602 has 255 bipartisan cospon-
sors, including 50 Republicans, representing well over half of the
House of Representatives (58%).18 An identical bill (S. 318) has
been introduced in the Senate by Minority Leader Tom Daschle
and Senators Edward Kennedy, Tom Harkin, and Christopher
Dodd.19 Our legislation has the support of over 100 organizations,
ranging from the American Cancer Society to the National Breast
Cancer Coalition to the American Academy of Pediatrics.
I wish I could say that this bill was prophylactic - that we had
not seen incidences of genetic discrimination arise yet. Unfortu-
nately, this is not the case. Allow me to share a few true stories
with you:
A woman took a genetic test for breast cancer based on numerous
cases among her family members and learned that she did indeed
carry the gene. She decided to have a prophylactic double mastec-
tomy and petitioned her insurer to cover the procedure without
sharing the genetic information. When the insurance company de-
nied her request, she revealed to them that she had the breast can-
cer gene. Upon learning this information, the insurer not only
denied her request, but canceled her policy as well.
20
Terri had received outstanding job evaluations and regular, gener-
ous raises for years. Upon going to the doctor for allergy problems,
however, she was diagnosed with Alphal, a disease that had killed
her brother. She began a regimen of treatments that would keep
her healthy and functional, carefully scheduling her appointments
on evenings, weekends, and vacation time. When her self-insured
employer learned about her condition, she was told that her ser-
18 Press Release, Senator Tom Daschle, Daschle Welcomes President Bush
to the Fight to Protect Americans from Genetic Discrimination available at http://
daschle.senate.gov/-daschle/pressroom/releases/01/06/2001627652.html (last vis-
ited June 25, 2001).
19 Id.
20 Press Release, Senator Tom Daschle, Daschle Remarks Prepared for De-
livery by Senate Democratic Leader Tom Daschle on the Introduction of the Ge-
netic Nondiscrimination in Health Insurance and Employment Act http://
daschle.senate.gov/-daschle/pressroom/releases/01/06/2001627652.html (last vis-
ited Feb. 13, 2001).
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vices were no longer needed and was asked to leave. The Equal
Employment Opportunity Commission is now suing Terri's em-
ployer on her behalf, alleging genetic discrimination. 21
As some of you may have seen in the news earlier this year, the
Burlington Northern Santa Fe Railroad was also sued by the EEOC
for genetic discrimination. 22 Workers filing disability claims related
to carpal tunnel syndrome were being tested without their knowl-
edge or consent for an extremely rare genetic condition that may
predispose some individuals to the disorder.23 The company evi-
dently hoped to avoid paying disability claims for any workers
found to have the gene.
24
Cases like these serve as a warning shot across our bow, fore-
shadowing more numerous and egregious cases of genetic discrimi-
nation in the future. As it is, the fear of genetic discrimination is
growing pervasive. 25 When I speak with scientists engaged in ge-
netic research, they tell me that it is growing increasingly difficult to
recruit participants for these studies. Even when confidentiality is
going to be rigorously protected, too many candidates still fear that
their genetic information could get out and be used against them.
26
21 Genetic Information in the Workplace: Hearing of the Senate Comm. on
Health, Education, Labor, and Pensions, 106th Cong. 80-81 (2000)(statement of
Terri Seargent), available at http://www.alphal.org/programs/newsmakers-
seargent.htm; What Every Woman Should Know About Genetic Discrimination,
NAT'L PARTNERSHIP, available at http://www.nationalpartnership.org/download/
geneticguide.txt (last visited Nov. 26, 2001).
22 Darryl Van Duch, EEOC Goes After Genetic Testing, NAT'L L.J., May 7,
2001, at B1; Steven Seidenberg, Mapping the Path of Genetic Bias Law, MIAMI
DAILY Bus. REV., Aug. 15, 2001, at 9.
23 Cheye Calvo, From Laboratories to Legislatures ... (Laws on Genetic
Testing), STATE LEGISLATURES, September 1, 2001, No. 8, Vol. 27, at 26; Steven
Seidenberg, Mapping the Path of Genetic Bias Law, MIAMI DAILY Bus. REV., Aug.
15, 2001, at 9.
24 60 Minutes II (CBS television broadcast, Apr. 10, 2001).
25 Genetic Information in the Workplace: Hearing of the Senate Comm. on
Health, Education, Labor, and Pensions, 106th Cong. 3-30 (2000) (statement of
Steven Paul Miller, Commissioner, U.S. Equal Employment Opportunity Commis-
sion); Paul S. Miller, Is There a Pink Slip in My Genes? Genetic Discrimination in
the Workplace, 3 J. HEALTH CARE L. & POL'Y 225, 232-238 (2000).
26 See e.g., Gina Kolata, Ticking Bomb: The Presence of a Breast-Cancer
Gene Creates Other Problems for Some Women, CHICAGO TRIBUNE, April 13, 1997
at 6.
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Furthermore, many Americans are deciding not to take genetic
tests due to their fear of discrimination. 27 I have spoken to numer-
ous people at conferences and other gatherings who come up to me
after my remarks and tell me that they would like to take a genetic
test for cancer or Alzheimer's, but that they fear the information
will not remain private. It is unconscionable that people are being
forced to deny themselves valuable health information simply be-
cause Congress has not acted to ban genetic discrimination.
THE PROSPECTS FOR ACTION
I hope you are all convinced by now that Congress must act to
ban genetic discrimination as soon as possible. The critical question
is, how likely is that to happen?
We face a daunting challenge. Although hard to believe, H.R.
602 has opposition that cannot be underestimated. 28 First and fore-
most, the health insurance industry opposes this legislation. 29 Al-
though they do not say so publicly, the insurance industry would
like very much to have access to genetic information.30 Since every
one of us has genetic flaws and could therefore ultimately be unin-
surable, this might not seem to make much sense. However, health
insurers know that most people carry a given policy only for a few
years.31 If they can determine whether a person might get seriously
ill in less than five years, this information could potentially have a
great benefit for the bottom line 32 - but it would be devastating
for all the individuals who lose their insurance coverage just when
they need it the most.
33
27 Wendy Lovejoy, Ending the Genetic Discrimination Barrier: Regaining
Confidence in Preconception, Prenatal, and Neonatal Genetic Testing, 74 S. CAL. L.
REV. 873, 890 (2001).
28 See e.g., William Roberts, Daschle Urges U.S. Senate Panel to Ban Genetic
Discrimination, BLOOMBERG NEWS, July 25, 2001 (indicating that the Biotechnol-
ogy Industry Organization, the Health Insurance Association of America, and the
U.S. Chamber of Commerce oppose the bill).
29 Genetic Discrimination: Venter, Industry Face Off On Bill, AMERICAN
HEALTH LINE, July 12, 2001; Congress Inclined to Bar Gene Testing, INSURANCE
CHRONICLE, July 16, 2001, Vol. 12, No. 29, at 1.
30 Larry R. Churchill, We Are Our Genes-Not! How Will Genetic Tests Be
Used? WORLD AND I MAGAZINE, Nov. 1, 2001, Vol. 16, No. 11, at 156; Steven
Brostoff, Patients' Bill Of Rights Could Be A Warm-Up For Emotional Genetic
Testing Issue, NAT'L UNDERWRITER, July 16, 2001, at 58.
31 Congress Inclined to Bar Gene Testing, supra note 29.
32 See Brostoff, supra note 30.
33 See Brostoff, supra note 30; see also Churchill, supra note 30.
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In addition, some pharmaceutical companies have concerns
about H.R. 602.34 They support the genetic nondiscrimination pro-
visions with great enthusiasm - *after all, if people cannot get
health insurance, they will not be able to afford the new genetic
therapies these companies are developing.35 But the pharmaceuti-
cal industry balks at the modest privacy protections included in the
bill.3 6 According to one drug company representative, these corpo-
rations would ultimately like to "partner" with HMOs and others to
browse through patients' records, identify those with certain genetic
information or predispositions, and then market their products di-
rectly to those individuals.37 As a lawmaker, I have profound con-
cerns about the implications of a practice like this for patient
privacy, the delivery of health care, and the potential increased
costs to government programs like Medicare and Medicaid.
With regard to employment discrimination, large employer
groups like the Chamber of Commerce and the National Associa-
tion of Manufacturers have expressed concerns with certain parts of
the employment sections of H.R. 602.38 While it is unclear when or
whether we might be able to reach agreement, I am heartened that
these groups have not opposed my bill outright. Cases like Burling-
ton Northern Santa Fe have made it more difficult for employers to
argue that nondiscrimination protections are unnecessary or
counterproductive.
34 Genetic Discrimination: Hearing Before the Subcommittee on Employer-
Employee Relations, July 24, 2001, (testimony of Harold Coxson, Esq.) available at
http://edworkforce.house.gov/hearings/107th/eer/genetic72401/ coxson.htm.
35 See generally, Angela Liang, Gene Therapy: Legal and Ethical Issues for
Pregnant Women, 47 CLEV. ST. L. REV. 61 (1999) (discussing the implications of
the lack of opportunity for genetic testing for low income pregnant women without
heath insurance); see Wendy Lovejoy, Ending the Genetic Discrimination Barrier.
Regaining Confidence in Preconception, Prenatal and Neonatal Genetic Testing, 74
S. CAL. L. REV. 873, 892-893 (2001) (discussing the implications of lack of genetic
testing for millions of uninsured children).
36 Religious Action Center of Reform Judaism, ISSUES. Privacy, Medical
Records, available at http://www.rac.org/issues/issuepr.html.
37 See Gene Issues Take Root; Government is Starting to Recognize The Po-
tentially Enormous Societal Effects of New Discoveries and Devices, L.A. TIMES,
July 15, 2000, at B9 (voicing concern for financial conglomerates, consisting of in-
surers, investment companies and banks sharing genetic information).
38 See generally Genetic Information in the Workplace Hearing Before Senate
Health, Education, Labor & Pensions, 107 th Cong. (2000) (statement of Harold P.
Coxon, Shareholder in the National Labor and Employment Law Firm Ogletree,
Deakins, Nash, Smoak & Stewart, P.C.) (discussing employment concerns with leg-
islation concerning genetic testing).
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These industries have extremely powerful allies in Congress.39
As of July of this year, no standing committee of the U.S. House of
Representatives had ever held a hearing on genetic discrimination
issues. The chairmen of the oversight committees had bottled up
not only my bill, but the entire issue. There is no doubt in my mind
that groups like health insurers played a key role in those decisions.
In July, however, the situation changed. 40 Both the House
Committee on Energy and Commerce and the Committee on Edu-
cation and the Workforce held hearings on genetic discrimination. 41
This newfound interest in the issue seems to have stemmed, at least
in part, from a June 23 radio address delivered by President Bush in
which he called for legislation to ban genetic discrimination in
health insurance and employment.
42
Around the same time, another key circumstance changed in
our favor: the Senate switched from Republican to Democratic con-
trol.43 The Senate sponsors of my legislation are now the Majority
Leader and Chairman of the committee of jurisdiction.44 One hear-
ing was held in July, but the second, scheduled for mid-September,
was unfortunately derailed by the events of September 11. 45 Never-
theless, both Senators Daschle and Kennedy remain strongly com-
mitted to passage of this legislation.
46
39 See Greg Gordon & Andrew Donohue, Dozens in Congress Own Millions
in Drug Stocks, STAR TRIBUNE, Sept. 28, 2000, at 6A; see also Drug Companies:
Lobbying Spending Reaches All-Time High, AMERICAN HEALTH LINE, July 7,
2000.
40 See Erin Heath, Zipping Up Genes Discrimination, NAT'L J. Vol. 33, No.
29, July 21, 2001 see also Brostoff, supra note 30.
41 Genetic Non-Discrimination: Implications for Employers and Employees:
Hearing Before the House Comm. on Education and the Workforce, 1 07th Cong.
(2001) (statement of Rep. Sam Johnson).
42 See Karen Lee, State, Local Governments Advance Employment Laws,
EMPLOYEE BENEFIT NEWS, Aug. 1, 2001.
43 David Espo, Senate Balance Switches as Jeffords resolves to leave GOP
available at http://detnews.com/2001/politics/OlO5/23/-227599.htm (last visited May
23, 2001).
44 William Roberts, supra note 28; American Civil Liberties Union Press Re-
lease, ACLU Urges Senate to Take Immediate Action to Protect Against Genetic
Discrimination available at http://www.aclu.org/news/2000/n072000a.html (last vis-
ited July 1, 2001).
45 William Roberts, supra note 28 (July hearing on genetic discrimination).
46 American Civil Liberties Union Press Release, supra note 44.
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In the wake of that terrible tragedy, the legislative landscape
has changed profoundly in Congress.47 Very few initiatives outside
funding bills and antiterrorism legislation are being considered. I
am encouraged, though, that the committees have not completely
abandoned this proposal. My office continues to engage in staff-
level negotiations with the committees.
48
No one can predict today what will happen in Congress next
year. A great deal will depend upon whether further terrorist or
bioterrorist attacks take place. In my view, however, it is critically
important that Congress not lose sight of the other needs of the
nation. Bills like H.R. 602 should not fall by the wayside simply
because Congress is incapable of considering multiple priorities.
CONCLUSION
In conclusion, there is no question in my mind that we must
ban genetic discrimination now or face terrible consequences in the
future. If we allow genetic discrimination to become widespread
and then try to ban the practice, we will find it all but impossible to
put the genie back in the bottle.
The law is organic; it must change and adapt, just as individuals
do, in times of need. This concept may have been expressed best by
one of our nation's foremost legal minds, Thomas Jefferson, when
he wrote the following in 1816:
I am certainly not an advocate for frequent changes in
laws and constitutions. But laws and institutions must
go hand in hand with the progress of the human mind.
As that becomes more developed, more enlightened,
as new discoveries are made, new truths discovered
and manners and opinions change, with the change of
circumstances, institutions must advance also to keep
pace with the times. We might as well require a man to
wear still the coat which fitted him when a boy as civi-
lized society to remain ever under the regimen of their
barbarous ancestors.
49
47 Events of September 11 Spur Custody Procedures, Altered Legislative
Landscape, 78 No. 37 INTERPRETER RELEASES 1493.
48 See generally id.
49 Thomas Jefferson Memorial Statute Chamber Inscriptions, July 1816,
available at www.nps.gov/thje/memorial/in.scrip.htm (taken from a letter to Sa-
muel Kercheval).
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It is time for the United States to address the legal and ethical
challenges raised by genetic research. I hope you will all work with
me in ensuring that our nation passes a strong genetic nondiscrimi-
nation law.

